A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.
NCT06728969
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study aims to demonstrate the accuracy of the MT1 algorithm using the MindTension biometric sensor device as a diagnostic aid for healthcare providers in diagnosing ADHD in youth ages ≥ 6 to ≤17 years.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- ADHD
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 6 to 17 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- MindTension
- Last updated on ClinicalTrials.gov
- December 11, 2024
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Icahn School of Medicine at Mount Sinai · New York, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.